Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2012 (2012), Article ID 369565, 5 pages
http://dx.doi.org/10.1155/2012/369565
Review Article

Risk of Orthopedic Surgical Site Infections in Patients with Rheumatoid Arthritis Treated with Antitumor Necrosis Factor Alfa Therapy

1Department of Internal Medicine, Hospital SARAH Brasília, SARAH Network of Rehabilitation Hospitals, SMHS Quadra 301 Bloco A, 70.335-901 Brasília-DF, Brazil
2Department of Rheumatology, University of Brasília, SGAN 605, Av. L2 Norte, 70840-901 Brasília-DF, Brazil
3Department of Internal Medicine, University of Brasília, SGAN 605, Av. L2 Norte, 70840-901 Brasília-DF, Brazil

Received 27 October 2011; Accepted 15 December 2011

Academic Editor: Yehuda Shoenfeld

Copyright © 2012 Bernardo Matos da Cunha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Marques Neto, E. T. Gonçalves, L. Langen et al., “Estudo multicêntrico da prevalência da artrite reumatóide do adulto em amostras da população brasileira,” Revista Brasileira de Reumatologia, vol. 33, no. 5, pp. 169–173, 2002. View at Google Scholar
  2. D. A. Pappas and J. T. Giles, “Do antitumor necrosis factor agents increase the risk of postoperative orthopedic infections?” Current Opinion in Rheumatology, vol. 20, no. 4, pp. 450–456, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. “Registro Brasileiro de Monitorização de Terapias Biológicas em Doenças Reumáticas BIOBADABRASIL. Biobadamerica,” http://biobadaser.ser.es/biobadamerica/Brasil/cgi-bin/upload/documentacion.aspx.
  4. J. R. Curtis, A. Jain, J. Askling et al., “A comparison of patient characteristics and outcomes in selected european and U.S. rheumatoid arthritis registries,” Seminars in Arthritis and Rheumatism, vol. 40, no. 1, pp. 2–14.e1, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. E. Thompson, S. W. Rieder, and J. E. Pope, “TNF therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials,” Arthritis and Rheumatism, vol. 63, no. 6, pp. 1479–1485, 2011. View at Publisher · View at Google Scholar · View at PubMed
  6. J. P. Leombruno, T. R. Einarson, and E. C. Keystone, “The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events,” Annals of the Rheumatic Diseases, vol. 68, no. 7, pp. 1136–1145, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. D. M. Grennan, J. Gray, J. Loudon, and S. Fear, “Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery,” Annals of the Rheumatic Diseases, vol. 60, no. 3, pp. 214–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. K. G. Saag, G. G. Teng, N. M. Patkar et al., “American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 59, no. 6, pp. 762–784, 2008. View at Google Scholar
  9. J. Ledingham and C. Deighton, “Update on the British Society for Rheumatology guidelines for prescribing TNF-α blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001),” Rheumatology, vol. 44, no. 2, pp. 157–163, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. R. Koike, T. Takeuchi, K. Eguchi, and N. Miyasaka, “Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis,” Modern Rheumatology, vol. 17, no. 6, pp. 451–458, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. E. Jämsen, H. Huhtala, T. Puolakka, and T. Moilanen, “Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases,” Journal of Bone and Joint Surgery, vol. 91, no. 1, pp. 38–47, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. K. L. Ong, S. M. Kurtz, E. Lau, K. J. Bozic, D. J. Berry, and J. Parvizi, “Prosthetic joint infection risk after total hip arthroplasty in the medicare population,” Journal of Arthroplasty, vol. 24, no. 6, pp. 105–109, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Ridgeway, J. Wilson, A. Charlet, G. Katafos, A. Pearson, and R. Coello, “Infection of the surgical site after arthroplasty of the hip,” Journal of Bone and Joint Surgery, vol. 87, no. 6, pp. 844–850, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. K. Saleh, M. Olson, S. Resig et al., “Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program,” Journal of Orthopaedic Research, vol. 20, no. 3, pp. 506–515, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. D. M. Urquhart, F. S. Hanna, S. L. Brennan et al., “Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review,” Journal of Arthroplasty, vol. 25, no. 8, pp. 1216–1222, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Definição dos critérios nacionais de infecções relacionadas à assistência à saúde: prevenção de infecções do sítio cirúrgico (ISC). Agência Nacional de Vigilância Sanitária http://www.anvisa.gov.br/servicosaude/manuais/index.htm.
  17. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  18. G. A. Wells, B. Shea, D. O'Connell et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses, Ottawa Hospital Research Institute, Ottawa, Canada, 2010.
  19. A. A. den Broeder, M. C. Creemers, J. Fransen et al., “Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study,” Journal of Rheumatology, vol. 34, no. 4, pp. 689–695, 2007. View at Google Scholar · View at Scopus
  20. K. Kawakami, K. Ikari, K. Kawamura et al., “Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-α blockers: perioperative interruption of tumour necrosis factor-α blockers decreases complications?” Rheumatology, vol. 49, no. 2, pp. 341–347, 2010. View at Google Scholar
  21. S. Momohara, K. Kawakami, T. Iwamoto et al., “Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs,” Modern Rheumatology, vol. 21, no. 5, pp. 469–475, 2011. View at Google Scholar